Navigation Links
Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market Research
Date:7/25/2012

FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight into the needs of research scientists; boost effective product development decisions; streamline marketing budgets; learn how to gain more market share; understand the key strengths and weaknesses of competitors and identify opportunities.

(Logo: http://photos.prnewswire.com/prnh/20120725/CG46150)

Mesenchymal Stem Cells – Advances & Applications

In BioInformant's recently launched market report, analysis of grant activity, publications, and patent applications reveals that Mesenchymal Stem Cell (MSC) research activity increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Mesenchymal stem cells now represent fastest growing area of stem cell research.  While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products.

The new report identifies recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. It is your guide for how to profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research. 

To view free products samples and a full Table of Contents, visit: http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html

Complete 2012 U.S. Cord Blood Banking Industry Report

As of 2012, the cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now just 7 years later, there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.

This industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof247398-complete-2012-us-cord-blood-banking-industry.html

Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products

The potential medical advances made possible from the use of human embryonic stem cells (hESC) are huge. These stem cells are able to develop into any of over 200 different cell types. So it's no surprise that the scientific research community is enthusiastically exploring all possibilities.

And where there is significant and growing interest from scientists, there is an opportunity for a company like yours to increase revenue from supplying stem cell products. There is no doubt it's an exciting market in which to expand your product range. But with embryonic stem cells there are serious market entry barriers to consider - namely a complex intellectual property scene.

This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof242923-opportunities-human-embryonic-stem-cell-product.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
2. Speakers Announced for the 2012 International Iridoid Research Symposium
3. Joslin Diabetes Center Convenes Leaders in Diabetes Prevention, Treatment, Payment, Education and Research at Diabetes Innovation 2012
4. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
5. University of Ottawa Medical Research Arm Eliminates Storage Boundaries with EMC Isilon
6. Promotional Trends Report from Encuity Research Shows Maneuvering to Fill Lipitor Vacuum
7. Enteral Feeding Devices Industry is Expected to Reach USD 2,447.6 Million Globally in 2018: Transparency Market Research
8. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
9. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
10. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
11. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):